IRON - Disc Medicine, Inc.
61.1
-3.260 -5.336%
Share volume: 643,076
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$64.36
0.00
0.00%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 02-27-2025 | 05-07-2025 | 11-06-2025 | 02-26-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | ||||
| Operating expenses | 34.550 M | 39.946 M | 67.696 M | 66.970 M | |
| Selling general and admin | 9.753 M | 12.183 M | 17.362 M | 20.746 M | |
| Research and development | 24.797 M | 27.763 M | 50.334 M | 46.224 M | |
| Total expenses | 34.550 M | 39.946 M | 67.696 M | 66.970 M | |
| 15.62% | 69.47% | -1.07% | |||
| Operating income | -34.550 M | -39.946 M | -67.696 M | -66.970 M | |
| Ebit | -34.550 M | -39.949 M | -67.714 M | -66.972 M | |
| Pretax income | -29.281 M | -33.966 M | -62.219 M | -60.443 M | |
| 16.00% | 83.18% | -2.85% | |||
| Income tax | 176.000 K | 119.000 K | 102.000 K | 88.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -29.457 M | -34.085 M | -62.321 M | -60.531 M | |
| -15.71% | -82.84% | 2.87% |